<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>advanced medical technologies - Latest Comments</title><link xmlns="http://www.w3.org/2005/Atom" rel="http://api.friendfeed.com/2008/03#sup" href="http://disqus.com/sup/all.sup#forumcomments-a184af8d" type="application/json"/><link>http://medmarket.disqus.com/</link><description>opinions, insights and inside data from founder of MedMarket Diligence</description><language>en</language><lastBuildDate>Wed, 24 Jun 2009 09:55:28 -0000</lastBuildDate><item><title>Re: Worldwide coronary stents market</title><link>http://mediligence.com/blog/2009/04/21/worldwide-coronary-stents-market/#comment-11680342</link><description>As a patient, you should only ask your doctor about specific manufacturers and their products, since different types and locations of occlusions, patient health status and other factors will determine the appropriate procedure and device. Also, don't assume that if you need angioplasty, you also need a stent.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">twitter-16982549</dc:creator><pubDate>Wed, 24 Jun 2009 09:55:28 -0000</pubDate></item><item><title>Re: Worldwide coronary stents market</title><link>http://mediligence.com/blog/2009/04/21/worldwide-coronary-stents-market/#comment-11672148</link><description>Ok, so I need to have an &lt;a href="http://www.ecommunity.com/cardiovascular/" rel="nofollow"&gt;angioplasty&lt;/a&gt;. Should I request certain manufacturers for a stent?</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">LincolnB</dc:creator><pubDate>Wed, 24 Jun 2009 08:41:15 -0000</pubDate></item><item><title>Re: Medtronic is dead and all the innovation that goes with it (with me so far?)</title><link>http://mediligence.com/blog/2009/06/21/medtronic-is-dead-and-all-the-innovation-that-goes-with-it-with-me-so-far/#comment-11563965</link><description>Sounds like Medtronic is stuck in a red ocean. The radical innovator at least has the advantage that there are no alternatives to their product. &lt;br&gt;&lt;br&gt;There is another issue in regards to financing. Realize that a doctor's AR is not an asset that they can get financing on. They cannot factor their receivables, because of the discounting done by the insurance companies. &lt;br&gt;&lt;br&gt;If healthcare has a problem, it is the insurance companies.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David Locke</dc:creator><pubDate>Mon, 22 Jun 2009 12:31:52 -0000</pubDate></item><item><title>Re: Dynamic stabilization (posterior): interspinous process spacers in spine surgery</title><link>http://mediligence.com/blog/2009/06/16/dynamic-stabilization-posterior-interspinous-process-spacers-in-spine-surgery/#comment-11543609</link><description>Thank You for this information.  It might be life saving, in my personal quest to find out what the alternatives are, and who is working on them.  &lt;br&gt;&lt;br&gt;SGB</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">SGB</dc:creator><pubDate>Sun, 21 Jun 2009 23:30:17 -0000</pubDate></item><item><title>Re: Common threads in new medical technology development</title><link>http://mediligence.com/blog/2009/06/01/common-threads-in-new-medical-technology-development/#comment-10699552</link><description>Excellent information! Thanks for posting.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Thom Ruhe</dc:creator><pubDate>Wed, 10 Jun 2009 11:26:20 -0000</pubDate></item><item><title>Re: Benign Prostatic Hypertrophy Pleads for Ablative Therapy</title><link>http://mediligence.com/blog/2008/10/16/bph-ablative/#comment-9859647</link><description>Very interesting. Hope to hear more from this progress.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">chiropractor seminars</dc:creator><pubDate>Sun, 24 May 2009 14:34:32 -0000</pubDate></item><item><title>Re: Medical technology platforms with high growth potential</title><link>http://mediligence.com/blog/2009/02/18/medical-technology-platforms-with-high-growth-potential/#comment-9737894</link><description>Nicely written.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">neil p</dc:creator><pubDate>Thu, 21 May 2009 13:58:01 -0000</pubDate></item><item><title>Re: Drug-Eluting Balloon Catheters</title><link>http://mediligence.com/blog/2009/03/17/drug-eluting-balloon-catheters/#comment-9007509</link><description>Now first Data from ELUTAX:&lt;br&gt;&lt;br&gt;The IASIS-CE Register is a project for registering the use of ELUTAX on the coronary vessels and in-stent restenosis&lt;br&gt;&lt;br&gt;30 Patients in instent Restenosis&lt;br&gt;&lt;br&gt;6 months angiographic follow-up&lt;br&gt;0% Restenosis&lt;br&gt;&lt;br&gt;&lt;br&gt;Also Elutax release more than 75% of drug after first inflation!</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dr. med. Alexander Ruebben</dc:creator><pubDate>Tue, 05 May 2009 05:38:16 -0000</pubDate></item><item><title>Re: High strength medical glues and adhesives</title><link>http://mediligence.com/blog/2009/04/16/high-strength-medical-glues-and-adhesives/#comment-8321530</link><description>interesting article.  I sell ca glue and know of several instances of it being used for temporary emergency wound closure.  I look forward to it becoming a common resource and satisfactory alternative to suturing!</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Brad</dc:creator><pubDate>Sat, 18 Apr 2009 01:48:33 -0000</pubDate></item><item><title>Re: Meanwhile, American Medical Systems Corners a Market</title><link>http://mediligence.com/blog/2006/06/20/urology-acquisition/#comment-7296827</link><description>AMS is not a laser company. Nor do they care to understand lasers or the market. Almost all of the Laserscope people are gone along with their expertise. Such a waste on money and talent.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J</dc:creator><pubDate>Tue, 17 Mar 2009 15:47:15 -0000</pubDate></item><item><title>Re: Of PMAs, Medtronic and, well, Medtronic</title><link>http://mediligence.com/blog/2009/02/25/medtronic-and-medtronic/#comment-6677211</link><description>Not at all...  just trying to figure out what i was doing wrong.  thanks!</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Will</dc:creator><pubDate>Thu, 26 Feb 2009 22:21:58 -0000</pubDate></item><item><title>Re: Of PMAs, Medtronic and, well, Medtronic</title><link>http://mediligence.com/blog/2009/02/25/medtronic-and-medtronic/#comment-6634082</link><description>Sorry, but I still count 58.  Are you looking at &lt;a href="http://www.fda.gov/cdrh/pma/pmajan09.html?" rel="nofollow"&gt;http://www.fda.gov/cdrh/pma/pmajan09.html?&lt;/a&gt;&lt;br&gt;&lt;br&gt;And, in any event, this doesn't change the thrust of the point being made, does it?</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">padraic526</dc:creator><pubDate>Thu, 26 Feb 2009 01:02:18 -0000</pubDate></item><item><title>Re: Of PMAs, Medtronic and, well, Medtronic</title><link>http://mediligence.com/blog/2009/02/25/medtronic-and-medtronic/#comment-6633658</link><description>I only count 55 for Medtronic...</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Will</dc:creator><pubDate>Thu, 26 Feb 2009 00:33:18 -0000</pubDate></item><item><title>Re: An ebb tide lowers all boats, but medtech is still afloat</title><link>http://mediligence.com/blog/2009/02/10/growth-markets/#comment-6153021</link><description>Patrick--great stuff!  This will ease the minds of some of the med-tech start-ups we're working with through SARTA's MedStart initiative in Sacramento.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Laura Good</dc:creator><pubDate>Tue, 10 Feb 2009 20:07:24 -0000</pubDate></item><item><title>Re: Medtech is not recession-proof, but so what?</title><link>http://mediligence.com/blog/2009/01/02/medtech-is-not-recession-proof-but-so-what/#comment-5706755</link><description>All good points.  You've elucidated more detail than my fundamental point, which was that, in essence, "a sinking tide lowers all boats", even medtech, but medtech is still going to be floating on top.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">padraic526</dc:creator><pubDate>Fri, 30 Jan 2009 14:57:36 -0000</pubDate></item><item><title>Re: Medtech is not recession-proof, but so what?</title><link>http://mediligence.com/blog/2009/01/02/medtech-is-not-recession-proof-but-so-what/#comment-5705677</link><description>I think there's two main considerations here.  The first is the fact that the healthcare sector at large is not immune to market volatility.  As such, the same exposure that other sectors are experiencing is being felt in the healthcare (med-tech, biotech, devices, health IT, etc) space.  Many investors think healthcare is recession-proof, but both patient demand for services fluctuates with macro and market volatility, as well as the decrease in credit market stability will have a significant impact on the ability of healthcare organizations to invest in technology.  I wrote up two pieces on this very issue recently, one on why healthcare is not recession-proof (&lt;a href="http://reiboldt.com/?p=507" rel="nofollow"&gt;http://reiboldt.com/?p=507&lt;/a&gt;) and the other on how we're already seeing the impact of the credit crunch reduce hospitals' investment in new technologies (&lt;a href="http://reiboldt.com/?p=530" rel="nofollow"&gt;http://reiboldt.com/?p=530&lt;/a&gt;).  &lt;br&gt;&lt;br&gt;The other side of the coin, however, says that there could be a great deal of opportunity as a "new" healthcare delivery system emerges from this crisis where technology lies at the heart of the system's efficiency.  So, healthcare providers and patients, in addition to ancillary healthcare firms, will become dependent on technology (just like almost every other sector already is) in the delivery of healthcare services, which will ultimately create a lot of opportunity for med-tech firms et al.  The question, though, is how do we get from where we are today (i.e., archaic, inefficient system) to that point of technological dependency and efficiency?  One answer could lie in what we're seeing happen on a daily basis in Washington.  Within the economic stimulus, there are provisions that will make way for more than $30 billion in additional spending on enhancing healthcare information technology, with special attention on achieving full-scale implementation of electronic health records within five years.  While the issue of the stimulus can be debated, this specific provision could mean a great deal of opportunity for the healthcare sector.  Again, another piece I just wrote on this issue yesterday can be found here:  &lt;a href="http://reiboldt.com/?p=548" rel="nofollow"&gt;http://reiboldt.com/?p=548&lt;/a&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mark</dc:creator><pubDate>Fri, 30 Jan 2009 14:16:40 -0000</pubDate></item><item><title>Re: New medtech startups, identified by name</title><link>http://mediligence.com/blog/2008/10/28/new-medtech-startups-identified-by-name/#comment-5549372</link><description>I don't know of this company and it is not coming up on any searches.  Do you have any more information on them?  Where are they located?</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">padraic526</dc:creator><pubDate>Mon, 26 Jan 2009 10:07:20 -0000</pubDate></item><item><title>Re: New medtech startups, identified by name</title><link>http://mediligence.com/blog/2008/10/28/new-medtech-startups-identified-by-name/#comment-5547653</link><description>I would like to add one more:&lt;br&gt;Intoration medical systems [ it main product are for heart and diabetic patients ]</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">zanu</dc:creator><pubDate>Mon, 26 Jan 2009 06:16:53 -0000</pubDate></item><item><title>Re: Insurer targeting low hanging fruit &amp;#8212; spine surgeries</title><link>http://mediligence.com/blog/2009/01/05/insurer-targeting-spine-surgeries/#comment-5535269</link><description>Degenerative disc disease is not prevented by excercise, nor is scoliosis and many other conditions for which spine surgery is used.  Your point is certainly well taken for preventive approaches, but it's just not as relevant for spine surgery.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">padraic526</dc:creator><pubDate>Sun, 25 Jan 2009 15:08:03 -0000</pubDate></item><item><title>Re: Insurer targeting low hanging fruit &amp;#8212; spine surgeries</title><link>http://mediligence.com/blog/2009/01/05/insurer-targeting-spine-surgeries/#comment-5534571</link><description>A lot of people don`t exercise and they interact with low back pains, so instead having an expensive surgery you should prevent it.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Health Advice</dc:creator><pubDate>Sun, 25 Jan 2009 14:16:06 -0000</pubDate></item><item><title>Re: Refractive Surgery: Procedure Trends in Ophthalmology</title><link>http://mediligence.com/blog/2007/09/05/refractive-surgery/#comment-5524776</link><description>Thank you for such a thorough listing of the different types of LASIK procedures.  Many clients and people exploring the LASIK procedure don't fully understand all of the different types.&lt;br&gt;&lt;br&gt;You have done a great job with this article and thank you for helping spread the information about LASIK and all of the refractive procedures that can be completed to improve one's vision.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lasik Eye Surgery Institute</dc:creator><pubDate>Sat, 24 Jan 2009 19:50:52 -0000</pubDate></item><item><title>Re: Spine Surgery Market Growth Rates</title><link>http://mediligence.com/blog/2008/10/08/spine-market-growth/#comment-5478322</link><description>Kevin, these growth rates are for revenues, with the rate on each year reflecting growth in revenue from prior year to that year.  Hope this helps.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">padraic526</dc:creator><pubDate>Thu, 22 Jan 2009 17:09:24 -0000</pubDate></item><item><title>Re: Spine Surgery Market Growth Rates</title><link>http://mediligence.com/blog/2008/10/08/spine-market-growth/#comment-5477986</link><description>Are these growth rates based on procedures or revenue/</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kevin Armstrong</dc:creator><pubDate>Thu, 22 Jan 2009 16:54:11 -0000</pubDate></item><item><title>Re: Obesity Device Market Growth Rates Vary Widely by Country</title><link>http://mediligence.com/blog/2008/12/04/obesity-market-country-growth/#comment-5227311</link><description>Wow, with the demand going up for weight loss surgery devices maybe it is a sign of how our diets are getting so poor. Between the processed sugars and white flour, our bodies are only doing what they were designed to do - store food in case of starvation. Too bad our bodies make us feel good when we do bad things for it.</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">weightlosssurgery</dc:creator><pubDate>Fri, 16 Jan 2009 19:14:47 -0000</pubDate></item><item><title>Re: Technologies at new medtech startups</title><link>http://mediligence.com/blog/2009/01/07/technologies-at-new-medtech-startups/#comment-5068697</link><description>RT: &lt;a rel="nofollow" href="http://twitter.com/medmarket"&gt;@medmarket&lt;/a&gt; New TweetBack This Button &lt;a href="http://tinyurl.com/9gr8mu" rel="nofollow"&gt;http://tinyurl.com/9gr8mu&lt;/a&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">medmarket (Patrick Driscoll)</dc:creator><pubDate>Sat, 10 Jan 2009 03:28:18 -0000</pubDate></item></channel></rss>